Conor Smith, BSc

Parexel International
Sheffield, England, United Kingdom

I do not have any relevant financial / non-financial relationships with any proprietary interests.

Presentation(s):

• 1586 - Phase 3/3b Experience with Long-Acting Cabotegravir and Rilpivirine: Efficacy and Safety Outcomes Through Week 96 by Race

  Friday, October 21, 2022
  4:15 PM - 4:30 PM US ET